BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:13 PM
Sep 10, 2012
 |  BC Extra  |  Company News

MedImmune, WuXi form Chinese JV for anti-IL-6 mAb

The MedImmune LLC biologics unit of AstraZeneca plc (LSE:AZN; NYSE:AZN) formed a 50/50 JV with WuXi PharmaTech Inc. (NYSE:WX) to develop and commercialize MedImmune's MEDI5117 in China...

Read the full 126 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >